Sarcoma

The 50 cancers under the umbrella of soft tissue sarcoma are marked by genetic chaos, and a growing understanding of these mutations may lead to new treatments.

Keytruda is showing benefit to some patients with sarcoma, according to interim results from a phase 2 trial.

CURE spoke with Noah Federman about the prevalence and treatment of sarcomas in younger patients.

The FDA granted olaratumab a priority review for some people with advanced soft tissue sarcoma (STS).

When it comes to fighting sarcoma, the Sarcoma Foundation of America does not stop at fundraising.

The breakthrough designation will expedite the development and review of this novel T-cell therapy in synovial sarcoma.

The approval of Halaven was based on an improvement in overall survival (OS) in a phase 3 study.

Based on this study, the monoclonal antibody is being investigated in an ongoing phase 3 study and has received an FDA Breakthrough Therapy Designation.

The approval is based on results from the phase 3 ET743-SAR-3007 trial.

Caregivers may grapple with practical and emotional challenges as they help loved ones manage cancer-related pain.